| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $1.3B | $3.4B | $1.3B | $0.8B | $1.3B | $0.5B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $-0.1B | $1.7B | $-0.1B | $-0.5B | $0.2B | $-0.3B | $0.8B |
| EPS (Basic) | $4.48 | $-0.60 | $10.59 | $-0.75 | $-2.31 | $0.88 | $-1.45 | $0.51 |
| EPS (Diluted) | $3.98 | $-0.60 | $8.99 | $-0.75 | $-2.31 | $0.87 | $-1.45 | $0.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.1B | $8.5B | $8.6B | $8.5B | $8.1B | $8.0B | $9.1B | $8.6B |
| Current Assets | $0.5B | $0.4B | $0.4B | $0.6B | $0.5B | $0.3B | $0.5B | $0.5B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $4.8B | $4.4B | $4.3B | $5.6B | $4.4B | $3.6B | $4.1B | $3.5B |
| Current Liabilities | $1.1B | $1.1B | $0.8B | $1.3B | $1.0B | $0.4B | $0.5B | $0.5B |
| Stockholders' Equity | $4.3B | $4.1B | $4.4B | $3.0B | $3.7B | $4.4B | $4.2B | $4.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.8B | $0.8B | $1.2B | $0.9B | $0.8B | $1.0B | $0.9B |
| Investing Cash Flow | $-0.9B | $-0.5B | $-0.5B | $-0.5B | $-0.4B | $-0.4B | $-1.1B | $-0.9B |
| Capital Expenditures | $0.5B | $0.5B | $0.7B | $0.6B | $0.5B | $0.5B | $1.2B | $1.1B |
| Financing Cash Flow | $-0.2B | $-0.3B | $-0.3B | $-0.7B | $-0.5B | $-0.4B | $0.2B | $-0.5B |